138 related articles for article (PubMed ID: 16014544)
1. Determination of ANA specificity using the UltraPlex platform.
Smith J; Onley D; Garey C; Crowther S; Cahir N; Johanson A; Painter S; Harradence G; Davis R; Swarbrick P
Ann N Y Acad Sci; 2005 Jun; 1050():286-94. PubMed ID: 16014544
[TBL] [Abstract][Full Text] [Related]
2. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
[TBL] [Abstract][Full Text] [Related]
4. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
6. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
7. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
8. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
11. [Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens].
Iwata H; Aotsuka S; Okawa M; Kinoshita M; Sumiya M
Ryumachi; 1997 Aug; 37(4):548-55. PubMed ID: 9311280
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens.
Martins TB; Burlingame R; von Mühlen CA; Jaskowski TD; Litwin CM; Hill HR
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1054-9. PubMed ID: 15539505
[TBL] [Abstract][Full Text] [Related]
13. HEp2 ANA EIA: a new fully automated assay for the screening of antinuclear antibodies.
Lehmann HP; Fühling I; Ott C; Hüdepohl B; Haass M
Isr Med Assoc J; 2000 Aug; 2(8):646-8. PubMed ID: 10979370
[TBL] [Abstract][Full Text] [Related]
14. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens.
Avaniss-Aghajani E; Berzon S; Sarkissian A
Clin Vaccine Immunol; 2007 May; 14(5):505-9. PubMed ID: 17376860
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.
Op De Beéck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2012 Dec; 12(2):137-43. PubMed ID: 22387973
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods.
Rouquette AM; Desgruelles C; Laroche P
Am J Clin Pathol; 2003 Nov; 120(5):676-81. PubMed ID: 14608892
[TBL] [Abstract][Full Text] [Related]
19. Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results.
Caramaschi P; Ruzzenente O; Pieropan S; Volpe A; Carletto A; Bambara LM; Biasi D
Rheumatol Int; 2007 May; 27(7):649-54. PubMed ID: 17136355
[TBL] [Abstract][Full Text] [Related]
20. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
